Valuation: Medpace Holdings, Inc.

Capitalization 14.09B 12.04B 11.1B 10.48B 19.47B 1,320B 19.96B 130B 51.12B 630B 52.89B 51.77B 2,251B P/E ratio 2026 *
28.8x
P/E ratio 2027 * 25.9x
Enterprise value 13.09B 11.19B 10.31B 9.73B 18.09B 1,226B 18.55B 121B 47.5B 586B 49.14B 48.1B 2,092B EV / Sales 2026 *
4.66x
EV / Sales 2027 * 4.19x
Free-Float
83.69%
Yield 2026 *
-
Yield 2027 * -
1 day+1.56%
1 week+0.58%
Current month+4.38%
1 month+12.93%
3 months-16.35%
6 months+0.00%
Current year-10.76%
1 week 487.34
Extreme 487.34
528.14
1 month 446.89
Extreme 446.8882
528.14
Current year 392.35
Extreme 392.35
628.92
1 year 250.05
Extreme 250.05
628.92
3 years 185.43
Extreme 185.43
628.92
5 years 126.94
Extreme 126.945
628.92
10 years 21.76
Extreme 21.76
628.92
Manager TitleAgeSince
Chief Executive Officer 69 30/06/1992
Director of Finance/CFO 51 31/07/2021
President 51 31/07/2021
Director TitleAgeSince
Chairman 69 30/06/1992
Director/Board Member 55 30/06/2016
Director/Board Member 72 30/06/2016
Change 5d. change 1-year change 3-years change Capi.($)
+1.56%+0.58%+68.36%+164.39% 14.09B
+0.39%+0.94%-1.26%-10.18% 45.62B
-1.30%-1.66%+32.68%+19.92% 34.34B
-2.25%-0.05%+26.01%+19.22% 29.46B
+2.78%-0.73%+18.17%-13.13% 28.09B
+41.35%+37.51%+281.58%+562.94% 19.11B
+3.87%+8.42%+64.61%+203.24% 14.78B
+11.87%+4.68%+3,276.98%+4,275.68% 14.25B
+1.15%-2.99%+36.63%+5.12% 13.25B
-0.29%+0.21%+168.64%+104.84% 12.42B
Average +5.92%-1.18%+397.24%+533.20% 22.54B
Weighted average by Cap. +4.60%-0.89%+261.39%+349.57%

Financials

2026 *2027 *
Net sales 2.81B 2.4B 2.21B 2.09B 3.88B 263B 3.98B 25.9B 10.18B 126B 10.54B 10.31B 448B 3.02B 2.58B 2.38B 2.25B 4.18B 283B 4.28B 27.9B 10.97B 135B 11.35B 11.11B 483B
Net income 497M 424M 391M 369M 686M 46.52B 704M 4.58B 1.8B 22.22B 1.86B 1.83B 79.37B 552M 471M 435M 410M 762M 51.67B 782M 5.09B 2B 24.67B 2.07B 2.03B 88.14B
Net Debt -1B -854M -788M -743M -1.38B -93.63B -1.42B -9.23B -3.63B -44.72B -3.75B -3.67B -160B -1.41B -1.2B -1.11B -1.05B -1.95B -132B -2B -13B -5.11B -63.01B -5.29B -5.18B -225B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.
Employees
6,200
Date Price Change Volume
13/04/26 501.23 $ +1.56% 203,881
10/04/26 493.53 $ -1.59% 192,107
09/04/26 501.50 $ -3.68% 364,439
08/04/26 520.65 $ +2.39% 507,078
07/04/26 508.52 $ +2.52% 329,532
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
493.53USD
Average target price
500.08USD
Spread / Average Target
+1.33%

Quarterly revenue - Rate of surprise